Answers are grounded in this paper and cite their sources.
The findings of the extension study through 12 months suggest that a second TearCare® treatment after 6 months provides additional improvement in the signs and symptoms of DED.
No takes yet. Share an insight, caveat, or question.
David Badawi (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: